Skip to main content
. 2021 Sep 5;35(5):2359–2365. doi: 10.1111/jvim.16255

TABLE 2.

Summary of responses to a questionnaire sent to owner of Beagles with Lafora disease regarding additional neurological deficits, changes in cognitive function and behavioral changes (n = 28)

Group of clinical signs Clinical signs Absolute number of dogs experiencing the clinical sign/number of responses; relative number in brackets
Additional neurological deficits Frequent blinking 12/25 (48%)
Impaired vision 15/26 (58%)
Impaired hearing 13/26 (50%)
Difficulties climbing stairs 18/25 (72%)
Loss of coordination 21/25 (84%)
Stiffness during walking 15/25 (60%)
Myoclonus during sleeping 24/25 (96%)
Changes in cognitive function Loss of housetraining (defecation) 2/25 (8%)
Loss of house training (urination) 8/25 (32%)
Difficulties performing learned tasks 9/25 (36%)
Difficulties learning new tasks 7/23 (30%)
impaired orientation in unknown surrounding 9/25 (35%)
general mental decline 10/25 (40%)
Behavioral changes Noise sensitivity 14/26 (54%)
Photosensitivity 20/26 (77%)
Sleepiness 16/26 (61%)
Changes in wake–sleep‐cycle 4/26 (15%)
Reduced playfulness 12/26 (46%)
Separation anxiety 11/25 (44%)
Aggression toward humans 5/26 (19%)
Aggression toward animals 2/26 (8%)
Staring into space 16/25 (64%)
Restless pacing 11/26 (42%)
Reduced stress resistance 15/26 (58%)
Panic attacks 7/25 (28%)
Anxiousness 13/25 (52%)
Reclusiveness 11/25 (44%)
Attachment to the owner 7/25 (28%)
Changes in appetite 4/20 (20%)

Note: Frequencies of observed clinical signs are provided as absolute and relative numbers.